Related Experiment Video

Updated: May 29, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

Receptor-mediated endocytosis of α-galactosidase A in human podocytes in Fabry disease

Thaneas Prabakaran1, Rikke Nielsen, Jakob V Larsen

  • 1Section of Cell Biology, Department of Anatomy, Aarhus University, Aarhus, Denmark.

Plos One
|September 28, 2011
PubMed

Insights

Researchers identified three endocytic receptors in human podocytes, offering new pathways for enzyme replacement therapy in Fabry disease. This discovery targets globotriaosylceramide accumulation and enhances kidney podocyte drug delivery.

Area of Science:

  • Nephrology
  • Cell Biology
  • Drug Delivery

Background:

  • Glomerular podocyte injury is central to human kidney diseases.
  • Fabry disease involves podocyte damage due to globotriaosylceramide buildup.
  • Podocyte repair presents a critical therapeutic avenue.

Purpose of the Study:

  • To identify endocytic receptors in human podocytes for targeted drug delivery.
  • To investigate the potential of these receptors for enzyme replacement therapy in Fabry disease.
  • To explore novel, non-carbohydrate-based drug delivery strategies to kidney podocytes.

Main Methods:

  • Identification of endocytic receptors in human podocytes.
  • Assessment of mannose 6-phosphate/insulin-like growth II receptor, megalin, and sortilin.
  • Evaluation of sortilin's expression and binding capabilities with alpha-galactosidase A.

Main Results:

  • Three endocytic receptors (mannose 6-phosphate/insulin-like growth II receptor, megalin, sortilin) were identified in human podocytes.
  • Sortilin, a novel alpha-galactosidase A binding protein, showed both intracellular and surface expression.
  • These receptors demonstrated potential for enzyme replacement therapy delivery.

Conclusions:

  • The study validates the rationale for alpha-galactosidase A treatment in Fabry disease.
  • Identified endocytic receptors provide pathways for future non-carbohydrate drug delivery to kidney podocytes.
  • These findings open avenues for treating Fabry disease and other kidney disorders affecting podocytes.

More Related Videos

Generation of Patient-Derived Podocytes from Skin Biopsies08:52

Generation of Patient-Derived Podocytes from Skin Biopsies

Published on: May 26, 2023

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins09:12

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Published on: January 18, 2019

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...